Celldex Therapeutics, Inc.CLDXNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+17.2%
5Y CAGR+24.8%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+17.2%/yr
vs +9.0%/yr prior
5Y CAGR
+24.8%/yr
Recent deceleration
Acceleration
+8.2pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
3x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $43.80M | +13.6% |
| 2024 | $38.55M | +24.7% |
| 2023 | $30.91M | +13.7% |
| 2022 | $27.20M | +32.7% |
| 2021 | $20.49M | +41.7% |
| 2020 | $14.46M | -6.3% |
| 2019 | $15.43M | -19.9% |
| 2018 | $19.27M | -22.9% |
| 2017 | $25.00M | -30.5% |
| 2016 | $35.98M | - |